Author

Letícia Silva Ferraz

Universidade Federal do Rio de JaneiroORCID 0000-0002-7915-0081Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alana S O Souza· 1 shared Bruna Rodrigues Cardoso MirandaiD· 1 shared Carla Verissimo· 1 shared Helena L. BorgesiD· 1 shared João Marcos de Azevedo DelouiD· 1 shared Julia S. M. ConceiçãoiD· 1 shared Martín BonaminoiD· 1 shared Mayra CarneiroiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alana S O Souza

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintApr 19, 2026

CDK4/6 inhibitors enhance oxaliplatin efficacy in colorectal cancer with RB-dependent and tumor-selective activity in intestinal model

Alana S O Souza, Julia S. M. Conceição, Letícia Silva Ferraz…·Helena L. Borges

This study shows CDK4/6 inhibitors synergize with oxaliplatin in colorectal cancer, with RB-dependent tumor-selective activity and preserved efficacy at low inhibitor doses.

DOI 10.64898/2026.04.15.718743

humanbulk RNA-seq

𝕏 PostBluesky